A comprehensive study of immune function and immunophenotyping of white blood cells from β-thalassaemia/HbE patients on hydroxyurea supports the safety of the drug
Hydroxyurea (HU) (hydroxycarbamide) is used as a therapeutic option in β-thalassaemia to increase fetal haemoglobin, which results in a reduced requirement for blood transfusion. However, a potential serious adverse effect of HU is neutropenia. Abnormal neutrophil maturation and function in β-thalas...
Saved in:
Main Author: | Siriworadetkun S. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/82445 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Impaired neutrophil extracellular trap formation in β-thalassaemia/HbE
by: Rattanawan Thubthed, et al.
Published: (2022) -
Hydroxyurea responses and fetal hemoglobin induction in β-thalassemia/HbE patients' peripheral blood erythroid cell culture
by: Ramida Watanapokasin, et al.
Published: (2018) -
Impaired neutrophil extracellular trap formation in β-thalassaemia/HbE
by: Thubthed R.
Published: (2023) -
Elevated levels of circulating monocytic myeloid derived suppressor cells in splenectomised β-thalassaemia/HbE patients
by: Sirikwan Siriworadetkun, et al.
Published: (2020) -
Microparticles from β-thalassaemia/HbE patients induce endothelial cell dysfunction
by: Wasinee Kheansaard, et al.
Published: (2019)